PATENT CLAIM ANALYSIS

Application Number: 15754414
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "416000"]

Abstract:
The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d 90 ) ranging from 1 μm to 100 μm.

Claim (Index 33):
A dry powder blending process for the manufacture of oral solid pharmaceutical compositions in form of a capsule according to  claim 31 , comprising the steps of:\n a. Milling a crystalline modification of Lenalidomide selected from the group comprising Lenalidomide base, Lenalidomide hydrochloride salt, Lenalidomide ammonium chloride cocrystal or mixtures thereof; b. Blending the milled Lenalidomide and first part of the filler(s) to obtain blend 1; c. Blending of blend 1 and second part of the filler(s) to obtain blend 2; d. Blending of disintegrant(s) and lubricant(s) to obtain blend 3; e. Sifting of blend 3; f. Blending of blend 2 and blend 3 (Lubrication) to obtain the final blend; g. Filling of capsules with the final blend.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.31707
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14780495', '15852125', '11776012', '15387317', '13736699']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.714438484203342
- 35 USC 102 Novelty (BERT): 0.4861941259067445
- Combined Prediction Score: 0.6916140483736823
- Mean Citation Score: 200.706194
- Max Citation Score: 204.72156
- Similarity Product: 159.6850561763477

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test